Hemin
- Generic Name
- Hemin
- Brand Names
- Panhematin
- Drug Type
- Biotech
- CAS Number
- 16009-13-5
- Unique Ingredient Identifier
- 743LRP9S7N
Overview
Hemin (trade name Panhematin) is an iron-containing porphyrin. More specifically, it is protoporphyrin IX containing a ferric iron ion (heme B) with a chloride ligand.
Background
Hemin (trade name Panhematin) is an iron-containing porphyrin. More specifically, it is protoporphyrin IX containing a ferric iron ion (heme B) with a chloride ligand.
Indication
Used in the management of porphyria attacks, particularly in acute intermittent porphyria.
Associated Conditions
- Acute Porphyria
- Hereditary Coproporphyria (HCP)
- Variegate Porphyria
Clinical Trials
FDA Approved Products
Panhematin
Manufacturer:RECORDATI RARE DISEASES, INC.
Route:INTRAVENOUS
Strength:7 mg in 1 mL
Approved: 2024/02/14
NDC:55292-702
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath